News

Children with Alagille syndrome who have lower blood levels of bile acids, the main component of the digestive fluid bile, have better long-term liver…

In preclinical studies, AT-587, Atea Pharmaceuticals’ lead oral candidate for treating hepatitis E, showed potent antiviral activity against multiple strains of the hepatitis…

Use of the experimental immune-modulating therapy CNP-104 in adults with primary biliary cholangitis (PBC) participating in a U.S. clinical trial led to greater reductions in markers…

Among children and adolescents with progressive familial intrahepatic cholestasis (PFIC), severe itch significantly affects sleep, overall perceptions of health, and the family’s quality of…

People whose biological parents were overweight or obese at the time of their conception face a greater risk of early liver disease, according to a…

The American Liver Foundation (ALF) has brought its “Bili the Brave” children’s book to life with a new animated video that aims to support…

One-time treatment with VRON-0200 reduced hepatitis B virus (HBV) levels in the blood of most people with chronic hepatitis B — early trial findings…

People with primary biliary cholangitis (PBC) who don’t start treatment after being diagnosed with the liver disease end up hospitalized more often and for…

Progressive familial intrahepatic cholestasis type 3 (PFIC3) can cause abnormalities in copper metabolism that mimic another condition, Wilson’s disease, and early distinction is key…

A new add-on blood test called the FAP-Index may help accurately identify serious liver scarring in people with metabolic dysfunction-associated steatotic liver disease (MASLD),…